Literature DB >> 29133515

"Rather one more chemo than one less…": Oncologists and Oncology Nurses' Reasons for Aggressive Treatment of Young Adults with Advanced Cancer.

Katsiaryna Laryionava1, Pia Heußner2,3, Wolfgang Hiddemann2, Eva C Winkler4.   

Abstract

BACKGROUND: Empirical research demonstrates that there is a tendency to administer tumor-directed therapy to patients with advanced cancer close to death, especially if they are young. The aim of this qualitative study was to understand oncologists' treatment decisions and oncology nurses' perception of these decisions in young adult patients and to investigate the extent to which young age was a factor in cancer treatment decisions.
MATERIALS AND METHODS: We conducted 29 face-to-face interviews with oncologists and oncology nurses at the Department of Hematology and Oncology at the University Hospital in Munich, Germany. The interviews were analyzed according to the grounded theory approach.
RESULTS: Oncologists and nurses reported that decisions about limiting cancer treatment with young adult patients are the most challenging and stressful in clinical practice. Apart from using young age as a proxy for patient's medical fitness, oncologists' decisions in favor of more aggressive treatment of younger patients were mainly guided by ethical reasons such as patient preferences and the perceptions of injustice associated with dying at a young age, as well as by psychological reasons, such as identification and emotional entanglement.
CONCLUSION: "Struggling" together with the patient against the injustice of dying young for a longer lifetime is an important factor driving aggressive treatment in young adult patients. However, oncologists might run a risk of neglecting other ethical aspects, such as a principle of nonmaleficence, that might even result in life-shortening adverse events. IMPLICATIONS FOR PRACTICE: This study identifies two ethical and one psychological reasons for patients' overtreatment: 1) patients' preference for further treatment; 2) oncologists' perception of un-fairness of dying young; and 3) identification and emotional entanglement with patient. These findings emphasize the need for oncologists' awareness of the reasons guiding their treatment decisions - a sole focus on patients' preferences and on the fighting against the unfairness of dying young might lead to neglecting obligations of non-maleficence. Self-reflection, the balance of empathy and professional distance as well as timely end of life discussions and involvement of psycho-oncologists are needed in the care of young cancer patients. © AlphaMed Press 2017.

Entities:  

Keywords:  Chemotherapy; End‐of‐life care; Medical ethics; Qualitative research; Young adult

Mesh:

Year:  2017        PMID: 29133515      PMCID: PMC5813748          DOI: 10.1634/theoncologist.2017-0094

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  40 in total

1.  Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study.

Authors:  Hilde M Buiting; Mette L Rurup; Henri Wijsbek; Lia van Zuylen; Govert den Hartogh
Journal:  BMJ Support Palliat Care       Date:  2011-06       Impact factor: 3.568

2.  Ethical assessment of life-prolonging treatment.

Authors:  Eva C Winkler; Wolfgang Hiddemann; Georg Marckmann
Journal:  Lancet Oncol       Date:  2011-08       Impact factor: 41.316

Review 3.  Intergenerational equity: an exploration of the 'fair innings' argument.

Authors:  A Williams
Journal:  Health Econ       Date:  1997 Mar-Apr       Impact factor: 3.046

Review 4.  Early palliative care for patients with metastatic cancer.

Authors:  Jan Gaertner; J Wolf; R Voltz
Journal:  Curr Opin Oncol       Date:  2012-07       Impact factor: 3.645

5.  Is there ageism in oncology?

Authors:  D Austin; E M Russell
Journal:  Scott Med J       Date:  2003-02       Impact factor: 0.729

6.  Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

7.  Sympathy, empathy, and physician resource utilization.

Authors:  S D Nightingale; P R Yarnold; M S Greenberg
Journal:  J Gen Intern Med       Date:  1991 Sep-Oct       Impact factor: 5.128

8.  Burden on oncologists when communicating the discontinuation of anticancer treatment.

Authors:  Hiroyuki Otani; Tatsuya Morita; Taito Esaki; Hiroshi Ariyama; Koichiro Tsukasa; Akira Oshima; Keiko Shiraisi
Journal:  Jpn J Clin Oncol       Date:  2011-07-15       Impact factor: 3.019

9.  Trends in receiving chemotherapy for advanced cancer patients at the end of life.

Authors:  Hee Seung Lee; Kyeong Hyeon Chun; Dochang Moon; Hahn Kyu Yeon; Sanghoon Lee; SooHyeon Lee
Journal:  BMC Palliat Care       Date:  2015-03-13       Impact factor: 3.234

Review 10.  Psychosocial screening and assessment in oncology and palliative care settings.

Authors:  Luigi Grassi; Rosangela Caruso; Silvana Sabato; Sara Massarenti; Maria G Nanni
Journal:  Front Psychol       Date:  2015-01-07
View more
  3 in total

1.  Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study.

Authors:  Dorothy McCaughan; Eve Roman; Alexandra G Smith; Anne C Garry; Miriam J Johnson; Russell D Patmore; Martin R Howard; Debra A Howell
Journal:  Eur J Oncol Nurs       Date:  2019-02-07       Impact factor: 2.398

2.  A qualitative study on the challenges health care professionals face when caring for adolescents and young adults with an uncertain and/or poor cancer prognosis.

Authors:  V W G Burgers; M J van den Bent; A-S E Darlington; A E Gualthérie van Weezel; A Compter; J M Tromp; R I Lalisang; M C M Kouwenhoven; L Dirven; N C G L Harthoorn; C A Troost-Heijboer; O Husson; W T A van der Graaf
Journal:  ESMO Open       Date:  2022-05-06

3.  Malignant Peritoneal Mesothelioma: A Challenging Case for Palliative Care.

Authors:  Carolina Vidal; Inês Romero; Isabel Neto
Journal:  Cureus       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.